Levemir and Humulin n drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Levemir (insulin detemir recombinant) and Humulin n (insulin susp isophane recombinant human). Common drug interactions include dyspnoea among females and nausea among males.

The phase IV clinical study analyzes what interactions people have when they take Levemir and Humulin n. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.

What is Levemir?

Levemir has active ingredients of insulin detemir recombinant. It is often used in diabetes. eHealthMe is studying from 13,850 Levemir users. Check the latest studies of Levemir.

What is Humulin n?

Humulin n has active ingredients of insulin susp isophane recombinant human. It is often used in diabetes. eHealthMe is studying from 9,878 Humulin n users. Check the latest studies of Humulin n.

On Jul, 12, 2026

37 people who take Levemir and Humulin n together, and have interactions are studied.

Levemir and Humulin n drug interactions.

What are the common drug interactions of Levemir and Humulin N, by gender? *:

female:

Dyspnoea (difficult or laboured respiration)
Back pain
Flushing (the warm, red condition of human skin)
Hunger
Injection site mass
Therapeutic response delayed (late preventive response)
Tremor (trembling or shaking movements in one or more parts of your body)
Abdominal discomfort
Alopecia (absence of hair from areas of the body)
Angioedema (rapid swelling of the dermis)

male:

Nausea (feeling of having an urge to vomit)
Dyspnoea (difficult or laboured respiration)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Depressed level of consciousness
Diarrhoea
Drug dependence
Drug ineffective
Drug tolerance increased
Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
Duodenitis (inflammation of the duodenum)

What are the common drug interactions of Levemir and Humulin N, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Abortion spontaneous (naturally occurring miscarriage)
Foetal death (death of foetus)
Injection site erythema (redness at injection site)
Injection site mass
Injection site pruritus (severe itching at injection site)

40-49:

Quality of life decreased
Renal impairment (severely reduced kidney function)
Sensory loss (senses loss)
Swelling
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Tachypnoea (a condition of rapid breathing over 20 per minute)
Tobacco abuse
Tobacco user
Nausea (feeling of having an urge to vomit)
Abdominal pain

50-59:

Blindness
Retinopathy (acute damage to the retina of the eye)
Visual acuity reduced (reduced clearness of vision)

60+:

Dyspnoea (difficult or laboured respiration)
Anaemia (lack of blood)
Injection site pain
Blood glucose decreased
Blood glucose increased
Dysphonia (speech disorder attributable to a disorder of phonation)
Neutropenia (an abnormally low number of neutrophils)
Pneumonia fungal
Thrombocytopenia (decrease of platelets in blood)
Transaminases increased

What are the existing conditions these people have? *

Type 2 Diabetes: 13 people, 35.14%
Pain: 3 people, 8.11%
High Blood Cholesterol: 3 people, 8.11%
Type 1 Diabetes: 2 people, 5.41%
Stress And Anxiety: 2 people, 5.41%
Neuropathy Peripheral (surface nerve damage): 2 people, 5.41%
High Blood Pressure: 2 people, 5.41%
Gestational Diabetes (diabetes in pregnancy): 2 people, 5.41%
Diabetic Retinopathy (damage to the retina caused by complications of diabetes): 2 people, 5.41%
Depression: 2 people, 5.41%

* Approximation only. Some reports may have incomplete information.

Do you take Levemir and Humulin n?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously